JAK2 and hepatic veno-occlusive disease: Circulating endothelial progenitor cells and liver endothelial cells may harbour the JAK2 mutation in patients with chronic myeloproliferative disorders, especially in patients who associate Budd Chiari syndrome, demonstrating the role of these cells in the pathogenesis of thrombosis, which may complicate the evolution of MPN.